US clinical-stage biotech developing microRNA-targeted therapies for oncology, with a lead candidate for acute myeloid leukaemia.
Create a free EquityFlow account to see Sanmirna Therapeutics's 1 funding round, 12 similar companies.
Sign up free → Sign in